Cellular origins of regenerating liver and hepatocellular carcinoma.
JHEP Rep
; 4(4): 100416, 2022 Apr.
Article
em En
| MEDLINE
| ID: mdl-35243280
BEC, biliary epithelial cell; CCl4, carbon tetrachloride; CDE, choline-deficient, ethionine-supplemented; DDC, 3,5-diethoxicarbonyl-1,4-dihydrocollidine; DEN, diethylnitrosamine; EpCAM, epithelial cell adhesion molecule; FLC, fibrolamellar carcinoma; Fah, fumarylacetoacetate hydrolase; Foxl1, forkhead box L1; HB, hepatoblastoma; HBV, hepatitis B virus; HCA, hepatocellular adenoma; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HDTVI, hydrodynamic tail vein injection; HNF, hepatocyte nuclear factor; HPC, hepatic progenitor cell; Hepatocellular carcinoma; HybHP, hybrid hepatocyte; ICC, intrahepatic cholangiocarcinoma; Krt19, cytokeratin 19; NASH, non-alcoholic steatohepatitis; OPN, osteopontin; PH, partial hepatectomy; Sox9, SRY-box 9; TAA, thioacetamide; carcinogenesis; hepatocyte; lineage tracing; progenitor cell
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article